{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:34:10Z","timestamp":1787646850098,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s15010-024-02428-1","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T10:41:15Z","timestamp":1732099275000},"page":"1321-1328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["JYNNEOS vaccine safety surveillance in the vaccine safety datalink during the 2022 mpox outbreak in the United States"],"prefix":"10.1007","volume":"53","author":[{"given":"Jonathan","family":"Duffy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Katherine","family":"Yih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimp","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini B.","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"Hambidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno J.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"Maro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"issue":"20","key":"2428_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.15585\/mmwr.mm7220a2","volume":"72","author":"JH McQuiston","year":"2023","unstructured":"McQuiston JH, Braden CR, Bowen MD, McCollum AM, McDonald R, Carnes N, et al. The CDC Domestic Mpox Response - United States, 2022\u20132023. MMWR Morb Mortal Wkly Rep. 2023;72(20):547\u201352. https:\/\/doi.org\/10.15585\/mmwr.mm7220a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2428_CR2","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak. (2023). Accessed January 25, 2024. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/vaccines\/vaccine-considerations.html"},{"key":"2428_CR3","unstructured":"Food and Drug Administration. JYNNEOS [package insert, revised June 2021]. AccessedJanuary 25, 2024. https:\/\/www.fda.gov\/media\/131078\/download"},{"key":"2428_CR4","unstructured":"Food and Drug Administration. Emergency use authorization for the emergency use of JYNNEOS. Accessed January 25, 2024. https:\/\/www.fda.gov\/media\/160774\/download"},{"issue":"42","key":"2428_CR5","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","volume":"32","author":"MM McNeil","year":"2014","unstructured":"McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, et al. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine. 2014;32(42):5390\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.073.","journal-title":"Vaccine"},{"key":"2428_CR6","doi-asserted-by":"publisher","first-page":"e48159","DOI":"10.2196\/48159","volume":"10","author":"L Qian","year":"2024","unstructured":"Qian L, Sy LS, Hong V, Glenn SC, Ryan DS, Nelson JC, et al. Impact of the COVID-19 pandemic on Health Care utilization in the Vaccine Safety Datalink: Retrospective Cohort Study. JMIR Public Health Surveill. 2024;10:e48159. https:\/\/doi.org\/10.2196\/48159.","journal-title":"JMIR Public Health Surveill"},{"issue":"15","key":"2428_CR7","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.vaccine.2022.11.027","volume":"41","author":"MS Gold","year":"2023","unstructured":"Gold MS, Amarasinghe A, Greenhawt M, Kelso JM, Kochhar S, Yu-Hor Thong B, et al. Anaphylaxis: revision of the Brighton collaboration case definition. Vaccine. 2023;41(15):2605\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.027.","journal-title":"Vaccine"},{"issue":"31","key":"2428_CR8","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","volume":"25","author":"JU Ruggeberg","year":"2007","unstructured":"Ruggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25(31):5675\u201384. https:\/\/doi.org\/10.1016\/j.vaccine.2007.02.064.","journal-title":"Vaccine"},{"issue":"4","key":"2428_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.2021.24110","volume":"327","author":"ME Oster","year":"2022","unstructured":"Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327(4):331\u201340. https:\/\/doi.org\/10.1001\/jama.2021.24110.","journal-title":"JAMA"},{"issue":"7","key":"2428_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/aje\/kwab022","volume":"190","author":"WK Yih","year":"2021","unstructured":"Yih WK, Kulldorff M, Dashevsky I, Maro JC. A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine. Am J Epidemiol. 2021;190(7):1253\u20139. https:\/\/doi.org\/10.1093\/aje\/kwab022.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2428_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/aje\/kwac030","volume":"191","author":"WK Yih","year":"2022","unstructured":"Yih WK, Kulldorff M, Dashevsky I, Maro JC. A Broad Safety Assessment of the recombinant herpes zoster vaccine. Am J Epidemiol. 2022;191(5):957\u201364. https:\/\/doi.org\/10.1093\/aje\/kwac030.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2428_CR12","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/aje\/kwy023","volume":"187","author":"WK Yih","year":"2018","unstructured":"Yih WK, Maro JC, Nguyen M, Baker MA, Balsbaugh C, Cole DV, et al. Assessment of Quadrivalent Human Papillomavirus Vaccine Safety using the self-controlled tree-temporal scan Statistic Signal-Detection Method in the Sentinel System. Am J Epidemiol. 2018;187(6):1269\u201376. https:\/\/doi.org\/10.1093\/aje\/kwy023.","journal-title":"Am J Epidemiol"},{"key":"2428_CR13","volume-title":"TreeScan: software for the tree-based scan statistic. 2.0 ed","author":"M Kulldorff","year":"2021","unstructured":"Kulldorff M, Information Management Services I. TreeScan: software for the tree-based scan statistic. 2.0 ed. Calverton, MD: Information Management Services, Inc; 2021."},{"key":"2428_CR14","unstructured":"See eg. 45\u00a0C.F.R. part 46.102(l)(2), 21\u00a0C.F.R. part 56; 42 U.S.C. \u00a7 241(d); 5 U.S.C. \u00a7 552a; 44 U.S.C. \u00a7 3501 et seq."},{"issue":"3","key":"2428_CR15","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","volume":"137","author":"MM McNeil","year":"2016","unstructured":"McNeil MM, Weintraub ES, Duffy J, Sukumaran L, Jacobsen SJ, Klein NP, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016;137(3):868\u201378. https:\/\/doi.org\/10.1016\/j.jaci.2015.07.048.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"2428_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/OLQ.0000000000001978","volume":"51","author":"J Duffy","year":"2024","unstructured":"Duffy J, Myers TR, Marquez P, Rouse D, Brown H, Zhang B, et al. JYNNEOS Vaccine Safety Surveillance during the 2022 Mpox Outbreak using the vaccine adverse event reporting system and V-safe, United States, 2022 to 2023. Sex Transm Dis. 2024;51(8):509\u201315. https:\/\/doi.org\/10.1097\/OLQ.0000000000001978.","journal-title":"Sex Transm Dis"},{"issue":"49","key":"2428_CR17","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.15585\/mmwr.mm7149a4","volume":"71","author":"J Duffy","year":"2022","unstructured":"Duffy J, Marquez P, Moro P, Weintraub E, Yu Y, Boersma P, et al. Safety Monitoring of JYNNEOS Vaccine during the 2022 Mpox outbreak - United States, May 22-October 21, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(49):1555\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7149a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"24","key":"2428_CR18","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","volume":"289","author":"JS Halsell","year":"2003","unstructured":"Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 2003;289(24):3283\u20139. https:\/\/doi.org\/10.1001\/jama.289.24.3283.","journal-title":"JAMA"},{"issue":"3","key":"2428_CR19","doi-asserted-by":"publisher","first-page":"e0118283","DOI":"10.1371\/journal.pone.0118283","volume":"10","author":"RJ Engler","year":"2015","unstructured":"Engler RJ, Nelson MR, Collins LC Jr., Spooner C, Hemann BA, Gibbs BT, et al. A prospective study of the incidence of myocarditis\/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination. PLoS ONE. 2015;10(3):e0118283. https:\/\/doi.org\/10.1371\/journal.pone.0118283.","journal-title":"PLoS ONE"},{"issue":"3","key":"2428_CR20","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1017\/dmp.2020.478","volume":"16","author":"AM Mandra","year":"2022","unstructured":"Mandra AM, Superior MJ, Guagliardo SAJ, Hesse E, Pacha LA, Stidham RA, et al. Myopericarditis Associated with Smallpox Vaccination among US Army Personnel - Fort Hood, Texas, 2018. Disaster Med Public Health Prep. 2022;16(3):1022\u20138. https:\/\/doi.org\/10.1017\/dmp.2020.478.","journal-title":"Disaster Med Public Health Prep"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02428-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02428-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02428-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:05:57Z","timestamp":1754352357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02428-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2428"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02428-1","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NPK reports research support from Pfizer, Sanofi Pasteur, Merck, GSK and Seqirus for unrelated work. MS reports research support from GSK for unrelated work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}